Starling Oncology, Inc. (STLN)
6.35
+0.14
(+2.17%)
USD |
NASDAQ |
Oct 02, 16:00
6.365
+0.02
(+0.24%)
After-Hours: 20:00
Starling Oncology Enterprise Value : 701.36M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 701.36M |
| October 01, 2026 | 687.80M |
| September 30, 2026 | 698.35M |
| September 29, 2026 | 717.44M |
| September 28, 2026 | 730.50M |
| September 25, 2026 | 732.51M |
| September 24, 2026 | 717.44M |
| September 23, 2026 | 748.58M |
| September 22, 2026 | 771.69M |
| September 21, 2026 | 749.59M |
| September 18, 2026 | 762.65M |
| September 17, 2026 | 729.49M |
| September 16, 2026 | 719.44M |
| September 15, 2026 | 703.37M |
| September 14, 2026 | 718.44M |
| September 11, 2026 | 683.28M |
| September 10, 2026 | 686.29M |
| September 09, 2026 | 695.33M |
| September 08, 2026 | 698.35M |
| September 04, 2026 | 659.16M |
| September 03, 2026 | 663.18M |
| September 02, 2026 | 675.24M |
| September 01, 2026 | 660.17M |
| August 31, 2026 | 657.15M |
| August 28, 2026 | 683.28M |
| Date | Value |
|---|---|
| August 27, 2026 | 700.36M |
| August 26, 2026 | 722.46M |
| August 25, 2026 | 696.34M |
| August 24, 2026 | 679.26M |
| August 21, 2026 | 712.91M |
| August 20, 2026 | 720.45M |
| August 19, 2026 | 732.51M |
| August 18, 2026 | 706.38M |
| August 17, 2026 | 697.34M |
| August 14, 2026 | 711.41M |
| August 13, 2026 | 692.32M |
| August 12, 2026 | 698.35M |
| August 11, 2026 | 685.79M |
| August 10, 2026 | 682.27M |
| August 07, 2026 | 707.39M |
| August 06, 2026 | 564.72M |
| August 05, 2026 | 568.74M |
| August 04, 2026 | 582.81M |
| August 03, 2026 | 578.79M |
| July 31, 2026 | 551.66M |
| July 30, 2026 | 572.76M |
| July 29, 2026 | 542.62M |
| July 28, 2026 | 560.70M |
| July 27, 2026 | 584.82M |
| July 24, 2026 | 563.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 2.112B |
| Agilon Health, Inc. | 1.188B |
| Nakamoto, Inc. | 318.50M |
| American Oncology Network, Inc. | -- |
| Sonida Senior Living, Inc. | 3.292B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.241M |
| Revenue (Quarterly) | 161.28M |
| Total Expenses (Quarterly) | 169.52M |
| EPS Diluted (Quarterly) | -0.08 |
| Gross Profit Margin (Quarterly) | 15.70% |
| Profit Margin (Quarterly) | -5.11% |
| Earnings Yield | -4.81% |
| Normalized Earnings Yield | -4.441 |